ArticleNanomedicine (London, England)2021

Micro- and nanotechnological delivery platforms for treatment of dysbiosis-related inflammatory bowel disease.

Dingpei Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.